BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33558661)

  • 1. Psychological distress in men with prostate cancer undertaking androgen deprivation therapy: modifying effects of exercise from a year-long randomized controlled trial.
    Galvão DA; Newton RU; Chambers SK; Spry N; Joseph D; Gardiner RA; Fairman CM; Taaffe DR
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):758-766. PubMed ID: 33558661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate Cancer Patients.
    Newton RU; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Bolam KA; Taaffe DR
    Med Sci Sports Exerc; 2019 Apr; 51(4):607-614. PubMed ID: 30395051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial.
    Taaffe DR; Newton RU; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Cormie P; Bolam KA; Galvão DA
    Eur Urol; 2017 Aug; 72(2):293-299. PubMed ID: 28249801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
    Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
    Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
    Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M
    Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of a 12-month supervised, intensive resistance, aerobic and impact exercise intervention on muscle strength in prostate cancer patients undergoing anti-hormone therapy: Study protocol for the randomized, controlled Burgdorf study.
    Reimer N; Hafke R; Wrensch M; Horst P; Bloch W; Hahn T; Kirchhoff A; Kluck KL; Stein J; Baumann FT
    Contemp Clin Trials; 2022 Mar; 114():106685. PubMed ID: 35065281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.
    Saini A; Berruti A; Cracco C; Sguazzotti E; Porpiglia F; Russo L; Bertaglia V; Picci RL; Negro M; Tosco A; Campagna S; Scarpa RM; Dogliotti L; Furlan PM; Ostacoli L
    Urol Oncol; 2013 Apr; 31(3):352-8. PubMed ID: 21803612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer.
    Newton RU; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Hayne D; Taaffe DR
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):457-464. PubMed ID: 32020032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.
    Newton RU; Taaffe DR; Spry N; Gardiner RA; Levin G; Wall B; Joseph D; Chambers SK; Galvão DA
    BMC Cancer; 2009 Jun; 9():210. PubMed ID: 19563641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-induced attenuation of treatment side-effects in patients with newly diagnosed prostate cancer beginning androgen-deprivation therapy: a randomised controlled trial.
    Ndjavera W; Orange ST; O'Doherty AF; Leicht AS; Rochester M; Mills R; Saxton JM
    BJU Int; 2020 Jan; 125(1):28-37. PubMed ID: 31605663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Physical and Mental Health in Patients with Prostate Cancer Undergoing Androgen Deprivation Therapy: Strategies to Promote and Improve Physical Activity Quality and Quantity.
    Toohey K; McKune A; Nahon I; Kavanagh PS; Newton RU; Paterson C
    Semin Oncol Nurs; 2020 Aug; 36(4):151051. PubMed ID: 32682582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
    Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
    Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?
    Newton RU; Taaffe DR; Spry N; Cormie P; Chambers SK; Gardiner RA; Shum DH; Joseph D; Galvão DA
    BMC Cancer; 2012 Sep; 12():432. PubMed ID: 23013489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.
    Wilding S; Downing A; Wright P; Selby P; Watson E; Wagland R; Donnelly DW; Hounsome L; Butcher H; Mason M; Henry A; Gavin A; Glaser AW
    Qual Life Res; 2019 Oct; 28(10):2741-2751. PubMed ID: 31115843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
    Lee M; Jim HS; Fishman M; Zachariah B; Heysek R; Biagioli M; Jacobsen PB
    Psychooncology; 2015 Apr; 24(4):472-7. PubMed ID: 24924331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Kilgour A; Lau YK
    BMC Cancer; 2012 Jul; 12():324. PubMed ID: 22846379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.
    Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ
    Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
    Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
    Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.